GeneBio’s Phenyx Chosen for ProteoRed Network
Complete the form below to unlock access to ALL audio articles.
Geneva Bioinformatics (GeneBio) SA and ProteoRed, the Spanish National Proteomics Network has announced that Phenyx would become the default protein identification software for ProteoRed with its installation at the National Center for Biotechnology/CSIC in Madrid.
ProteoRed network members, consisting of over 20 research institutions from all over Spain, will then be able to access and send data to this centralized server in order to perform proteomics research.
GeneBio’s Phenyx is a software platform for the identification and characterization of proteins and peptides from mass spectrometry data specifically designed to meet the concurrent demands of high-throughput MS data analysis and dynamic results assessment. (http://phenyx.vital-it.ch/pwi)
The objective of the ProteoRed consortium is to coordinate and integrate activities of the Spanish proteomics facilities and services in a common network with a nodal structure, so they will support the whole development of proteomics research in Spain.
ProteoRed offers services in all the stages involved in the protein analysis process: protein fractionation, separation and purification of peptides and proteins, protein and peptide molecular weight analysis, protein identification, characterization, sequencing and differential proteomics.
“We received many positive reviews of Phenyx from ProteoRed members and we were impressed by GeneBio’s responsiveness as they created a scoring scheme based on our specific needs,” said Dr. Juan Pablo Albar, General Coordinator of ProteoRed.
“Our goal is to offer our network a high performance computing server that can handle the various demands and necessities inherent in a much-used proteomics cluster; we have tested Phenyx within our IT architecture (an SGI cluster with Itanium processors), it performed admirably and thanks to features such as its customizable scoring, we believe it will more than cover the requirements of our network members in terms of reliability, accuracy, flexibility and of course speed.”
“To have Phenyx be used by a prestigious organization such as ProteoRed is indeed an honor and in line with our goals,” said Nasri Nahas, CEO of GeneBio. “Phenyx was designed for industrial use and massive scalability, and thus can accommodate both small and large cluster environments.
The addition of ProteoRed to our client list perfectly fits our strategy of targeting major proteomics clusters and offering Phenyx as a cornerstone of a partnership whereby GeneBio, through score optimization and other feature shaping, endeavors to create a tool that best meets the precise demands of customers.
Phenyx is already being utilized in large-scale projects such as the Swiss Institute of Bioinformatics’ Vital-IT initiative that hosts Phenyx’s public version and the HUPO Brain Proteome Project, among others. We look forward to a close working relationship with ProteoRed in order to maintain a formidable proteomics platform.”
